← Back to Search

Corticosteroid

Budesonide irrigation for Sinusitis

Phase 3
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after beginning of treatment
Awards & highlights
No Placebo-Only Group
Pivotal Trial

Summary

This trial is testing whether a nasal spray or a nose irrigation is more effective for people with chronic sinus problems who have not had surgery.

Eligible Conditions
  • Sinusitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after beginning of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after beginning of treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Disease specific quality of life questionnaire
Secondary study objectives
Endoscopic evaluation of the nasal cavities

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Budesonide irrigationExperimental Treatment1 Intervention
2 cc budesonide nebule (0,5 mg/cc) incorporated to 240 of saline water (Sinus Rinse) to be taken on a daily basis x 3 months
Group II: Mometasone nasal sprayActive Control1 Intervention
Mometasone nasal spray 50 mcg/dose, 2 sprays/nostril twice daily x 3 months Patients will also be taking Sinus Rinse once daily throughout the study period

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
304 Previous Clinical Trials
76,693 Total Patients Enrolled
1 Trials studying Sinusitis
16 Patients Enrolled for Sinusitis
~4 spots leftby Nov 2025